Active	Status	Sponsor type	Region	Phase	Filter
4 Active 4 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Shoemaker, Ashley
NCT04240821: Theophylline for Treatment of Pseudohypoparathyroidism	Enrolling by invitation	2	34	US	Theophylline ER, Theophylline elixir	Ashley Shoemaker	Pseudohypoparathyroidism, Pseudohypoparathyroidism Type 1a, Albright Hereditary Osteodystrophy	12/26	12/26
NCT04551170: Theophylline Treatment for Pseudohypoparathyroidism - Children 2-12 Years Old	Recruiting	2	34	US	Theophylline, Theo-24, Elixophyllin, Placebo	Vanderbilt University Medical Center	Pseudohypoparathyroidism, Albright Hereditary Osteodystrophy, Pseudohypoparathyroidism Type 1a	12/26	12/26
NCT03029429: Theophylline Treatment for Pseudohypoparathyroidism	Recruiting	2	34	US	Theophylline, Theo-24, Elixophyllin, Placebos, placebo	Vanderbilt University Medical Center, Harvard University	Pseudohypoparathyroidism, Albright Hereditary Osteodystrophy	07/26	11/26
NCT02957916: Vanderbilt Childhood Obesity Registry	Active, not recruiting	N/A	3000	US		Vanderbilt University Medical Center	Childhood Onset Obesity, Pediatric Obesity, Childhood Obesity	01/32	01/32